Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomized, open-label, phase 3b trial
Your doctor will go over your medical history and weight loss goals during your initial visit
Purchasers must be at least 21 years of age and agree to our Terms & Conditions at checkout.
Sourcing, Quality & Documentation RetaLABS Semaglutide is supplied as research-grade, manufacturer-verified lyophilised peptide
Omar BA, Liehua L, Yamada Y et al (2014) Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes
One level 1 hypoglycemic episode was reported in the study, while no level 2 and no severe hypoglycemic episodes were reported